| Warren Andrew Ong, MD | |
|
1443 Hartford Ave, Johnston, RI 02919 | |
| (401) 273-8100 | |
| (401) 553-1072 |
| Full Name | Warren Andrew Ong |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 32 Years |
| Location | 1443 Hartford Ave, Johnston, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003896101 | NPI | - | NPPES |
| 7005366 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 9162 (Rhode Island) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Thundermist Health Center | 1557270477 | 131 |
News Archive
There is no clinical evidence that hydroxychloroquine is effective against COVID19. Some studies using hydroxychloroquine have shown no benefits or even an increase in risk of death, but the number of clinical trials investigating hydroxychloroquine as a primary or secondary intervention continues to expand to determine whether the drug candidate is a key contender as a therapeutic or not, says GlobalData, a leading data and analytics company.
Attorney General Eric Holder and U.S. Department of Health and Human Services Secretary Kathleen Sebelius today joined private sector leaders, law enforcement personnel and health care experts for a landmark National Summit on Health Care Fraud. The summit is the first national gathering on health care fraud between law enforcement and the private and public sectors and is part of the Obama Administration's coordinated effort to fight health care fraud.
Today, the leading provider of High-Throughput Sequencing analysis solutions, CLC bio, announced that they're collaborating with premier German sequencing service provider, imaGenes, to better support the fast growing German market of high-throughput sequencing analyses. imaGenes, will provide all customers receiving Next Generation Sequencing data with a temporary license for CLC Genomics Workbench for assembly and downstream sequence analyses.
Several prominent cancer researchers are now joining forces in an advanced new cancer study. The goal is to understand which tumors will be difficult to treat and to find out why certain cancer drugs lose their effect after a period of use.
Neuroscientists at Georgetown University Medical Center have discovered a brain anomaly that explains why some people diagnosed with autism cannot easily recognize faces - a deficit linked to the impairments in social interactions considered to be the hallmark of the disorder.
› Verified 4 days ago
| Entity Name | The Providence Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104847946 PECOS PAC ID: 9739080292 Enrollment ID: O20040116000840 |
News Archive
There is no clinical evidence that hydroxychloroquine is effective against COVID19. Some studies using hydroxychloroquine have shown no benefits or even an increase in risk of death, but the number of clinical trials investigating hydroxychloroquine as a primary or secondary intervention continues to expand to determine whether the drug candidate is a key contender as a therapeutic or not, says GlobalData, a leading data and analytics company.
Attorney General Eric Holder and U.S. Department of Health and Human Services Secretary Kathleen Sebelius today joined private sector leaders, law enforcement personnel and health care experts for a landmark National Summit on Health Care Fraud. The summit is the first national gathering on health care fraud between law enforcement and the private and public sectors and is part of the Obama Administration's coordinated effort to fight health care fraud.
Today, the leading provider of High-Throughput Sequencing analysis solutions, CLC bio, announced that they're collaborating with premier German sequencing service provider, imaGenes, to better support the fast growing German market of high-throughput sequencing analyses. imaGenes, will provide all customers receiving Next Generation Sequencing data with a temporary license for CLC Genomics Workbench for assembly and downstream sequence analyses.
Several prominent cancer researchers are now joining forces in an advanced new cancer study. The goal is to understand which tumors will be difficult to treat and to find out why certain cancer drugs lose their effect after a period of use.
Neuroscientists at Georgetown University Medical Center have discovered a brain anomaly that explains why some people diagnosed with autism cannot easily recognize faces - a deficit linked to the impairments in social interactions considered to be the hallmark of the disorder.
› Verified 4 days ago
| Entity Name | Thundermist Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700041001 PECOS PAC ID: 1557270477 Enrollment ID: O20040211000909 |
News Archive
There is no clinical evidence that hydroxychloroquine is effective against COVID19. Some studies using hydroxychloroquine have shown no benefits or even an increase in risk of death, but the number of clinical trials investigating hydroxychloroquine as a primary or secondary intervention continues to expand to determine whether the drug candidate is a key contender as a therapeutic or not, says GlobalData, a leading data and analytics company.
Attorney General Eric Holder and U.S. Department of Health and Human Services Secretary Kathleen Sebelius today joined private sector leaders, law enforcement personnel and health care experts for a landmark National Summit on Health Care Fraud. The summit is the first national gathering on health care fraud between law enforcement and the private and public sectors and is part of the Obama Administration's coordinated effort to fight health care fraud.
Today, the leading provider of High-Throughput Sequencing analysis solutions, CLC bio, announced that they're collaborating with premier German sequencing service provider, imaGenes, to better support the fast growing German market of high-throughput sequencing analyses. imaGenes, will provide all customers receiving Next Generation Sequencing data with a temporary license for CLC Genomics Workbench for assembly and downstream sequence analyses.
Several prominent cancer researchers are now joining forces in an advanced new cancer study. The goal is to understand which tumors will be difficult to treat and to find out why certain cancer drugs lose their effect after a period of use.
Neuroscientists at Georgetown University Medical Center have discovered a brain anomaly that explains why some people diagnosed with autism cannot easily recognize faces - a deficit linked to the impairments in social interactions considered to be the hallmark of the disorder.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Warren Andrew Ong, MD 249 Roosevelt Ave, Suite 205, Pawtucket, RI 02860 Ph: (401) 724-8400 | Warren Andrew Ong, MD 1443 Hartford Ave, Johnston, RI 02919 Ph: (401) 273-8100 |
News Archive
There is no clinical evidence that hydroxychloroquine is effective against COVID19. Some studies using hydroxychloroquine have shown no benefits or even an increase in risk of death, but the number of clinical trials investigating hydroxychloroquine as a primary or secondary intervention continues to expand to determine whether the drug candidate is a key contender as a therapeutic or not, says GlobalData, a leading data and analytics company.
Attorney General Eric Holder and U.S. Department of Health and Human Services Secretary Kathleen Sebelius today joined private sector leaders, law enforcement personnel and health care experts for a landmark National Summit on Health Care Fraud. The summit is the first national gathering on health care fraud between law enforcement and the private and public sectors and is part of the Obama Administration's coordinated effort to fight health care fraud.
Today, the leading provider of High-Throughput Sequencing analysis solutions, CLC bio, announced that they're collaborating with premier German sequencing service provider, imaGenes, to better support the fast growing German market of high-throughput sequencing analyses. imaGenes, will provide all customers receiving Next Generation Sequencing data with a temporary license for CLC Genomics Workbench for assembly and downstream sequence analyses.
Several prominent cancer researchers are now joining forces in an advanced new cancer study. The goal is to understand which tumors will be difficult to treat and to find out why certain cancer drugs lose their effect after a period of use.
Neuroscientists at Georgetown University Medical Center have discovered a brain anomaly that explains why some people diagnosed with autism cannot easily recognize faces - a deficit linked to the impairments in social interactions considered to be the hallmark of the disorder.
› Verified 4 days ago
Dr. Albert Joseph Marano, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1524 Atwood Ave, Suite 244, Johnston, RI 02919 Phone: 401-272-7660 Fax: 401-421-2730 | |
Cyril O Burke Iii, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1524 Atwood Ave, Suite 120, Johnston, RI 02919 Phone: 401-521-9620 Fax: 401-521-4651 | |
Farhad Amani, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1443 Hartford Ave, Johnston, RI 02919 Phone: 401-273-8100 Fax: 401-553-1072 | |
Nicholas Gelormini, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1443 Hartford Ave, Johnston, RI 02919 Phone: 401-553-1000 Fax: 401-722-5280 |